Nucleome Therapeutics
Pre-clinicalA biotechnology company developing precision medicines by mapping the 3D genome and identifying disease-associated genetic variants.
Founded
2019
Focus
AntibodiesBiologicsSmall Molecules
About
A biotechnology company developing precision medicines by mapping the 3D genome and identifying disease-associated genetic variants.
Funding History
2Total raised: $41.7M
Series A$37.5MM VenturesJun 15, 2022
Seed$4.2MUndisclosedJun 15, 2019
Company Info
TypePrivate
Founded2019
LocationOxford, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile